These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7805962)

  • 1. The attitudes of women and feasibility of screening for ovarian and endometrial cancers in inner city practices.
    Wolfe CD; Raju KS
    Eur J Obstet Gynecol Reprod Biol; 1994 Aug; 56(2):117-20. PubMed ID: 7805962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
    Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
    N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of predictors of attendance for breast screening in inner London.
    Sutton S; Bickler G; Sancho-Aldridge J; Saidi G
    J Epidemiol Community Health; 1994 Feb; 48(1):65-73. PubMed ID: 8138773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
    Hall KL; Dewar MA; Perchalski J
    Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological impact of screening for familial ovarian cancer.
    Wardle FJ; Collins W; Pernet AL; Whitehead MI; Bourne TH; Campbell S
    J Natl Cancer Inst; 1993 Apr; 85(8):653-7. PubMed ID: 8468723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research in practice. Transvaginal screening.
    Kipps S
    Nurs Times; 1994 Jan 26-Feb 1; 90(4):44-8. PubMed ID: 8108260
    [No Abstract]   [Full Text] [Related]  

  • 7. Women at risk of ovarian cancer: attitudes towards and expectations of the familial ovarian cancer clinic.
    Sheppard R; Fry A; Rush R; Steel CM; Cull A
    Fam Cancer; 2001; 1(1):31-7. PubMed ID: 14574013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
    Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
    Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gynecological surveillance of women with Lynch syndrome in Sweden.
    Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
    Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which dimensions of health-related quality of life are altered in patients attending the different gynecologic oncology health care settings?
    Capelli G; De Vincenzo RI; Addamo A; Bartolozzi F; Braggio N; Scambia G
    Cancer; 2002 Dec; 95(12):2500-7. PubMed ID: 12467063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.
    Laaksonen MA; Arriaga ME; Canfell K; MacInnis RJ; Byles JE; Banks E; Shaw JE; Mitchell P; Giles GG; Magliano DJ; Gill TK; Klaes E; Velentzis LS; Hirani V; Cumming RG; Vajdic CM
    Gynecol Oncol; 2019 Jun; 153(3):580-588. PubMed ID: 30935715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone prevention strategies for breast, endometrial and ovarian cancers.
    Rice LW
    Gynecol Oncol; 2010 Aug; 118(2):202-7. PubMed ID: 20471672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of screening for ovarian cancer using symptoms as selection criteria.
    Rufford BD; Jacobs IJ; Menon U
    BJOG; 2007 Jan; 114(1):59-64. PubMed ID: 17233861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
    MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
    Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Cancer Is Associated With Dissatisfaction With Care-A Longitudinal Analysis Among Ovarian and Endometrial Cancer Patients.
    de Rooij BH; Ikiz H; Boll D; Pijnenborg JMA; Pijlman BM; Kruitwagen RFPM; van de Poll-Franse LV; Vos MC; Ezendam NPM
    Int J Gynecol Cancer; 2018 Mar; 28(3):614-622. PubMed ID: 29466257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of coffee, tea and caffeine intake with risk of breast, endometrial and ovarian cancer among Canadian women.
    Arthur R; Kirsh VA; Rohan TE
    Cancer Epidemiol; 2018 Oct; 56():75-82. PubMed ID: 30075330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The importance of screening in oncogynecology].
    Frühauf F; Sláma J; Zikán M
    Ceska Gynekol; 2014 Dec; 79(6):491-8. PubMed ID: 25585558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
    Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.